Vice President Of Operations And Business Development
Current• Successfully in-licensed 72 drugs, including 8 innovators, from 28 companies, in both multi-country and pan-continental deals.• Directed the company's first Clinical Development Investment, in collaboration with a Japanese partner, securing exclusive marketing rights for the innovative drug Darinaparsin across Latin America.• Founded and currently lead two R&D teams, that have successfully developed 10 drugs which are now approved and on the market in 3 countries. • Oversee and manage Expanded Access (Named Patient) Programs, facilitating the import and export of products into and across Colombia, Perú, Brazil, Argentina, México, and Trinidad & Tobago.• Execute out-licensing and sub-licensing operations of company products in various Latin American countries, including Brazil, Argentina, and México.• Expanded company operations into Perú, Ecuador, and Panamá.• Created and oversee Regulatory Affairs teams in Colombia, Perú, Ecuador, and Panamá, which have successfully registered 70 products.• Formulate and implement corporate strategies, including Annual Sales Forecasts and Market Access Plans. • Obtained Emergency Use Authorizations and launched 4 COVID 19 products in Colombia.